 |
|
Effect of Acetazolamide on Choroidal Morphology in Central Serous Chorioretinopathy
Jae Hyuck Kwak, Seung Woo Hong, Ho Ra, Eun Chul Kim, Nam Yeo Kang, Jiwon Baek
Korean J Ophthalmol. 2019;33(6):493-499. Published online 2019 Dec 5 DOI: https://doi.org/10.3341/kjo.2019.0063
|
|
Citations to this article as recorded by
 Current and emerging treatment options for central serous chorioretinopathy
Massimiliano Borselli, Costanza Rossi, Domenico Chisari, Giovanna Carnovale Scalzo, Andrea Lucisano, Giorgio Randazzo, Vincenzo Mollace, Vincenzo Scorcia, Adriano Carnevali
Expert Review of Ophthalmology.2024; 19(4): 247. CrossRef Choroidal modifications assessed by means of choroidal vascularity index after oral eplerenone treatment in chronic central serous chorioretinopathy
Lisa Toto, Maria Ludovica Ruggeri, Federica Evangelista, Pasquale Viggiano, Rossella D’Aloisio, Chiara De Nicola, Gennaro Falconio, Marta Di Nicola, Annamaria Porreca, Rodolfo Mastropasqua
Eye.2023; 37(6): 1214. CrossRef Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies
Xinyuan Zhang, Connie Zhi Fong Lim, Jay Chhablani, Yew Meng Wong
Eye and Vision.2023;[Epub] CrossRef Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review
Massimo Nicolò, Lorenzo Ferro Desideri, Aldo Vagge, Carlo Enrico Traverso
Pharmaceuticals.2020; 13(10): 264. CrossRef
|